company

H. Lundbeck A/S

as of 2026-07-01
Monitor thisAsk about this
at a glance
47 trials sponsored · 23 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

23 assets
AripiprazoleBrexpiprazole (Rexulti)OlanzapinePaliperidoneQuetiapineRisperidoneZiprasidoneBifeprunoxLu AE58054Lu AF11167Lu AF11167 (1-2 mg/day)Lu AF11167 (3-4 mg/day)Lu AF35700Lu AF35700 (10 mg/day)Lu AF35700 (30 mg/day)SerdolectSertindoleZicronapineZicronapine 10 mg dailyZicronapine 20 mg once weeklyZicronapine 30 mg once weeklyZicronapine 45 mg once weeklyZicronapine open-label lead-in 10 mg daily

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
small molecule
drug
Brexpiprazole (Rexulti)
small molecule
drug
Olanzapine
small molecule
drug
Paliperidone
small molecule
drug
Quetiapine
small molecule
drug
Risperidone
small molecule
drug
Ziprasidone
small molecule
drug
Bifeprunox
small molecule
drug